Neurofi bromatosis-1 (NF1) is one of the most common hereditary multisystemic disorders. The disease manifests a variety of characteristic features that include: hyperpigmentary abnormalities of the skin (café-au-lait macules, freckles in the axillae, and iris Lisch nodules) and growth of benign peripheral nerve sheath tumors (neurofi bromas) in the skin. Associated extracutaneous clinical features include: skeletal abnormalities, neurological, cardiovascular, endocrine and other malformations. NF1 is caused by mutation in the neurofi bromatosis-1 gene, which codes for the protein neurofi bromin. The inheritance of NF1 follows an autosomal dominant trait, although about 50% of patients present with new ("de novo") mutations, and represent the fi rst member of their family. No difference in the severity of the disease can be found in patients with familial mutations versus those with new mutations. We present a 78-year-old female patient with an extreme cutaneous form of neurofi bromatosis who reported no affected family member. Apart from skin problems, she had no major health issues in childhood and adolescence, but in recent decades she had frequent headaches, occasional abdominal pain, and vision and hearing impairment. About 10 to 14 days before admission, she developed a severe cough, shortness of breath, and chest and abdominal pain. On examination, the patient of short stature (hight: 152 cm, weight: 49 kg) presented with thousands of soft nodules dispersed over the whole body, except on extensor sides of thighs and lower legs; the nodules varied in color from skin-colored, livid erythematous, to brown-grey; the nodules on the abdomen were moist, partly bleeding from the base, and accompanied by an unpleasant odor. Her feet were also densely covered by dark purple lumps, with dystrophic changes of the toe nails that were thickened, frayed, and yellowish. The skeletal abnormalities included: short stature, severe osteoporosis and osteosclerosis of the head bone structure; degenerative arthropathc-spondylotic changes of the thoracolumbar spine segment with signs of diffuse skeletal hyperostosis; pronounced degenerative changes of the lumbar spine. CT scans of the head, chest and abdomen showed the following abnormalities: fl attening of the paraventricular gyri and reduction of brain parenchyma with hypodensity of the white matter in terms of cortical atrophy; periventricular bilateral small post-ischemic microvascular brain lesions of varying chronicity; in the parenchyma of the upper left lung lobe the apical presence of small areas of pleural effusion with consequent subatelectic region; distended stomach and a small inner wall herniation; hypotrophic right kidney; atherosclerotic lesions of the abdominal aorta; low grade infrarenal kinking of the abdominal aorta. Pathohistological analysis of biopsy specimen taken from the nodule corresponded with cutaneous neurofi broma. Consultative examinations of various specialists pointed to the existence of the following comorbidities: obstructive respiratory syndrome and right lobe pneumonia that were treated by antibiotics, aminophylline and dexamethasone infusions; psycho-organic syndrome without focal neurological defi cit; Lisch nodules in each eye, and senile cataract. Considering the age and medical presentation of the patient, no other treatment was considered. In conclusion, this is a sporadic case of cutaneous neurofi bromatosis 1 in a 78-year-old female patient who presented with extremely severe cutaneous neurofi bromas, making this case at least rather peculiar.
N eufi bromatoses (NFs) comprise several distinct genetic disorders that lead to the formation of tumors involving nerve tissue. Th e two main forms are NF1 and NF2, the fi rst also known as von Recklinghausen disease with characteristic skin lesions, opposite to the second which does not present with cutaneous manifestations (1) .
Neurofi bromatosis 1 (NF1), or von Recklinghausen disease, is a multisystemic disorder that aff ects approximately 1 in 3.500 people (2) . Althouh the earliest historical descriptions originate from the 13 th century, in 1882, Friederich von Recklinghausen published a landmark paper On the Multiple Fibromas of the Skin and Th eir Relationship to the Multiple Neuromas, describing this disease and pointing out that the skin tumors were derived from peripheral nerves (3) . More recently, in 1956, Crowe, Schull and Neel published a milestone manuscript detailing the numerous manifestations of this disorder (4, 5) . NF1 is caused by a heterozygous mutation in the NF1 gene located on chromosome 17 which encodes a protein named neurofi bromin. Th e NF1 gene has one of the highest mutation rates among all other genes within the human genome. More than 500 diff erent mutations in the NF1 gene have been identifi ed. Th e mode of inheritance is autosomal dominant, with almost 100% penetrance by the age of 5 years (1). Familial occurrence is reported in about half of aff ected individuals, the rest are sporadic cases resulting from a high gene mutation rate which accounts for 50% of all cases (6) . Since each aff ected individual and family has specifi c mutations, genetic screening is highly challenging (1) . No diff erence in the severity of the disease can be found in patients with familial mutations versus those with new mutations. Major diagnostic criteria for NF1, established by the National Institutes of Health (NIH) are based on clinical fi ndings and require 2 or more of the following criteria: 6 or more "cafe au lait macules" (CALMs) with diameter > 5 mm and >15 mm in prepubertal and postpubertal patients, respectively; ≥2 of any type of neurofi bromas, or at least 1 plexiform neurofi broma; axillary or inguinal freckling; ≥ 2 Lisch nodules on the iris; distinctive osseous lesion; an optic nerve glioma; fi rst-degree relative with NF1. Th e hallmark features of the disorder are CALMs and neurofi bromas. Th e disease is not only a neurocutaneous but also a multisystemic disorder, with multifaceted implications throughout nearly every organ system in the human body. Th e most common extracutaneous complications are related to skeletal abnormalities, ophthalmic, neurological, endocrine, vascular and cardiac disorders including tumors (7) . Th e treatment of NF1 focuses on symptom management, as well as radio-and chemotherapy in case of malignant alterations. Other treatment options include lovastatin, rapamycin (or sirolimus), imatinib mesylate and even topical vitamin D3 analogues (8) .
Case report
We present a 78-year-old female patient, resident of the Gerontology Centre in Banja Luka, who was referred to the Clinic of Skin and Venereal Diseases of the University Clinical Center of the Republic of Srpska, due to itching in the area of anterior abdominal wall, coughing, shortness of breath, chest and abdominal pain. On admission, the patient reported having skin tumors since childhood, whose number gradually increased, especially after 30 years of age, and they covered the skin of her entire body; due to learning diffi culties, she could not read or write, and no other family member, including seven brothers and two sisters, who are all alive except one brother, had similar skin tumors. Th is information was confi rmed by the head nurse and director of the Gerontology Center who are in contact with her family. Apart from skin lesions, she had no major health problems in childhood and youth, but in recent decades she had frequent headaches, occasional abdominal pain, and vision and hearing impairment. Th e patient also reported an elbow surgery on her left arm a few decades ago; she had no other health problems, and apart from analgesics, she was not taking other medications. Since no proper medical documentation was available, and she had a scar on her elbow, we assumed that she underwent surgical excision of one of the largest tumors. About 10 to 14 days before admission, she developed a severe cough, shortness of breath, and chest and abdominal pain.
Physical examination
On examination, the patient of short stature (height: 152 cm, weight: 49 kg) presented with thousands of soft nodules dispersed over the whole body, except Four typical "café au lait" spots of diff erent sizes were found on the trunk and lower extremities, as well as 4 -5 smaller pale brown maculae ( Figure 8) . A large number of brownish spots were found in the inguinal region and on the inner sides of thighs ( Figure 9 ). Her feet were also densely covered by dark purple lumps, with dystrophic changes of the toe nails that were thickened, frayed, and yellowish.
Laboratory and other test results
Erythrocyte sedimentation rate 65 mm/h, C-reactive protein 147.5 mg/L (reference level <5.0 mg/L), white blood cell count 9.2x10 9 /L (reference range 3.4 -9.3) with neutrophils 80.8% (reference range 40 -77%), lymphocytes 11.7% (reference range 16 -44); red on extensor sides of thighs and lower legs ( Figures 1  -3) ; the nodules varied in color from skin-colored, livid erythematous, to brown-grey; the nodules on the abdomen were moist, partly bleeding from the base, and accompanied by an unpleasant odor (Figure 4) . Th e size of nodules ranged from 0.5 cm to 15 cm in diameter, many of which had elongated patellar base; some nodules were covered by comedones ( Figure 5 ); nodules were most densely grouped in the occipital and abdominal region, and along the central part of the back forming clusters ( Figure 6 Microbiology testing: Staphylococcus aureus and Viridans streptococci were isolated from the skin specimens collected from the surface of the infl ammed nodules.
Microbiology testing of nasal swabs: Proteus mirabilis was isolated.
Microbiology testing of throat swabs: normal fl ora. Native abdominal X-ray: normal fi ndings. X-ray of the lower extremities and pelvis (standard views): bone structures showed no evidence of trauma or other pathological changes; normal joint width.
CT of the head: bone structures showed marked osteoporosis, as well as osteosclerotic lesions; fl attening of the paraventricular gyri and reduction of brain parenchyma with hypodensity of the white matter in terms of cortical atrophy; periventricular bilateral small post-ischemic microvascular brain lesions of varying chronicity.
Th oracic CT detected: in the lung parenchyma of the upper left lobe the apical presence of small area of pleural eff usion with consequent subatelectatic zone; left hilum of involutile appearance with posterobasal, partly anterior, as well as laterobasal parts of atelectasis; no signs of axillary or mediastinal lymph nodes enlargement; coronary vessels without pathological changes, no pericardial eff usions; bone structures showed no signs of infi ltrative changes; arthropathic-spondylotic degenerative changes of the thoracic-lumbar spine segment with signs of diff use skeletal hyperostosis.
CT of the abdomen revealed the following disorders: diff use fatty liver infi ltration; markedly distended stomach fi lled with heterogeneous contents; small inner stomach wall herniation, posterior and medially to the left; hypotrophic right kidney; atherosclerotic lesions of the abdominal aorta; 
Therapy
During the hospital stay, the patient received oral antibiotics (cephalexin capsules 2 x 1 g/day for ten days, followed by azithromycin 1 x 250 mg tablets/day for fi ve days), and dexamethasone and aminophylline infusions in 0.9% NaCl solution, plus oral ranitidine. Infl amed neurofi bromas were topically treated by aqueous solution of eosin 2%. She was discharged in good general condition, the infl ammation of neurofi bromas was managed and she showed no distinct respiratory symptoms. low grade infrarenal kinking of the abdominal aorta; pronounced degenerative changes in the lumbar spine.
Pathohistological analysis of biopsy specimens taken from the nodules corresponded to cutaneous neurofi broma (Figures 11 and 12 ).
Consultative examinations of various specialists pointed to the existence of the following comorbidities: obstructive respiratory syndrome and right lobe pneumonia that were treated by antibiotics, aminophylline and dexamethasone infusions; psychoorganic syndrome without focal neurological defi cit; Lisch nodules in each eye, and senile cataract.
Control laboratory tests
After the patient was dismissed from the hospital, control laboratory tests showed abnormal test results 
Discussion
Th e large NF1 gene is located on chromosome 17q11.2. Th is gene comprises 60 exons and spans 350 kb of genomic DNA. Th e protein product of this gene, neurofi bromin, consists of 2,818 amino acids and is present in various tissues, mostly in nervous tissue (6, 9) . Mast cells increase in neurofi bromas and may enhance growth of these tumors by producing several growth factors, such as histamine and tumor necrosis factor (TNF) (1) . Th e neurofi bromin protein shows signifi cant regions of similarity to the guanosine triphosphatese (GTPase)-activating protein and is capable of down-regulation of Ras activity. NF1 germline mutations cause haploinsuffi ciency of neurofi bromin, which is only 50% of the normal protein production by cells. Further investigations support the view that the NF1 gene acts as a suppressor of tumor activity, with a variety of somatic inactivating mutations identifi ed in neurofi bromas. Th e random acquisition of somatic mutation partly explains the delayed age of onset of the tumors associated with NF1 and variability of expression (1) . Neurofi bromin defi ciency aff ects cell types throughout the entire body, especially the neural crest cells that include Schwann cells, melanocytes, Figure 10 . Neurofi bromas on the dorsal aspect of feet criteria. Molecular genetic testing is feasible. Identifi cation of the NF1 gene means that prenatal/ presymptomatic diagnosis for this disease is now possible, with greater than 95% accuracy in families with aff ected members (1) . Th e clinical manifestations of NF1 usually appear in a certain order as age increases: café au lait macules (CALMs), axillary freckling, Lisch nodules, and neurofi bromas (9) . CALMs are frequently the fi rst sign of NF1, occurring in 99% of NF1 patients within the fi rst year of life (1, 3) . Th eir color can range from skin color to dark brown. Th e prevalence of CALMs in the general population has varied from 3% to 36% depending on the study groups selected, but the presence of multiple macules in the general population typically is less than 1% (12) . Patients continue to develop lesions throughout childhood, but they often fade in adulthood (13) .
Skinfold freckling (Crowe's sign) is the most specifi c of the cardinal criteria for NF1. It is considered and endoneurial fi broblasts (6, 9) . Consequently, the clinical manifestations of NF1 are extremely variable and unpredictable not only among individuals with this disease but with the same genotype.
Th e National Institutes of Health (NIH) Consensus Conference developed diagnostic criteria for NF1 that require at least two of the following clinical features, as outlined in Table 1 (10, 11) .
Th e diagnosis is established based of clinical (14) . Our patient presented with thousands of cutaneous neurofi bromas which is the third hallmark signs of NF1. Neurofi bromas usually do not become apparent until puberty and may continue to increase in size and number throughout adulthood. Neurofi bromas can occur anywhere on the body and there is a wide variation in their shape and size. Generally, the "cutaneous" tumors are domeshaped, soft, fl eshy as in our patient, their color varies from unchanged to slightly hyperpigmented. Th ey may have the pathognomonic buttonholelike invagination when pressed with a fi nger. "Subcutaneous" tumors are fi rm and nodular. Pregnancy induces tumor growth (9, 14) . Th e tumors are composed of Schwann cells, fi broblasts, mast cells, and perineural cells. Th ere is also an admixture of collagen and extracellular matrix. Th ere are several unusual, but well recognized variants of cutaneous neurofi bromas that were not seen in our patient. Th e fi rst are plexiform neurofi bromas, skeletal, ophthalmologic, neurologic/psychologic, cardiovascular, endocrine, gastrointestinal, as well as malignant (2, 9) ( Table 2 ). In fact, the diagnosis of NF1 is often made in the middle age or later in life, as in our patient. Th e enormous variability of presentations appears to be at least partially genetically determined and is unrelated to the unaff ected NF1 allele (1). Bone abnormalities in NF1 are variable and include scoliosis, sphenoid wing or long bone dysplasia, but recently osteopenia/osteoporosis has been noted. Th e underlying pathogenic mechanisms are not fully understood, but experimental evidences suggest that NF1-defi cient osteoblasts aff ect osteoclast diff erentiation leading to increased degradation of bone tissue. Scoliosis is the most common orthopedic fi nding in NF1, occurring in up to 10% of patients, being more apparent with aging and increases in puberty, suggesting a possible hormonal infl uence (1) . Th e pathogenesis of this fi nding in NF1 is unknown, but it may be related to osteopenia and subsequent dysplastic bony elements. Dysplasia of long bones is another common manifestation of NF1, occurring in nearly 14% of patients, and it is usually evident within the fi rst year of life. Th is fi nding is particularly relevant in dermatology, as young patients come to the Clinic for evaluation of "birthmarks" during the fi rst year of life and can be easily screened for this manifestation. Th e tibia is the most commonly aff ected bone, bowing in an anterolateral direction. Coupled with the appropriate number and size of CALMs, this orthopedic manifestation is suffi cient to make the diagnosis of NF1 at this age. Other fi ndings may include overgrowth of a limb or congenital pseudoarthrosis (usually of the tibia), in which a fracture heals abnormally. Other skeletal abnormalities include short stature, relative macrocephaly, and a prominent forehead and brow. Nevertheless, 29 -45% of patients with NF1 have a head circumference greater than or equal to two standard deviations above the mean for sex and age (17, 18) . Skeletal abnormalies detected in our patients were: short stature, head bone structures showed marked osteoporosis, as well as osteosclerotic lesions; degenerative spinal arthropathic spondylotic changes with signs of diff use skeletal hyperostosis; pronounced degenerative changes in the lumbar spine. uncommon variant of NF1 in which neurofi bromas arise from multiple nerves as bulging and deforming masses involving also connective tissue and skin folds. Plexiform neurofi bromas occur in up to 30% of cases with NF1, most frequently in the craniomaxillofacial region. Th ese tumors are diff use, growing along the length of a nerve and feel like a "bag of worms"; malignant progression is generally considered the main cause of mortality, occurring in 2 -16% of cases (15) . Th e second are blue-red and pseudoatrophic macules, unusual variants of cutaneous neurofi bromas (2, 6) . Th e increased serum levels of tumor markers were detected in our patient. Because of the extremely high number of tumors with diff erent sizes, malignant alteration could not be excluded in the patient, although we did not detect plexiform neurofi bromas.
Another common manifestation/symptom in NF1 is pruritus. Generally, it is a widespread cutaneous phenomenon, but anecdotally, some patients are able to distinguish certain tumors as more itchy than the others. Th e pathogenesis of this fi nding is uncertain, but may be related to the increased number of mast cells that are found in neurofi bromas. However, if localized, pruritus can be a clue for the presence of an underlying spinal cord or central nervous tumor (16) .
Our patient had all three cardinal skin manifestations: CALMs, groin freckling, and cutaneous neurofi bromas. What makes this case rather peculiar is extremely high number of cutaneous neurofi bromas of various sizes that covered almost the entire skin. Before being infl ammed, neurofi bromas in the abdominal region were very itchy causing severe scratching. On the rest of the skin, there were 4 typical and few faded CALMs. Due to the presence of fade CALMs, considering the patient's age, as well as the density and number of brownish neurofi bromas, the pre-existence of CALMs in early age was indicative. Although early onset and rapid progression before puberty usually indicates a poor prognosis, minimal cutaneous involvement in the young child does not necessarily imply a favourable course. Extensive involvement of the urinary or gastrointestinal tract or the central nervous system carries a poor prognosis (1) .
NF1 may aff ect almost every organ system, but the complaints vary between individuals, even within a single family. Extracutaneus fi ndings of NF1 are numerous, and usually include after the age of six) with accelerated linear growth as the evidence of early puberty, thus necessitating the use of growth charts in NF1 patients. Symptomatic optic gliomas are typically present prior to the age of six, with most children being diagnosed by the age of three (19) . Ophtalmological abnormalities in our patient included lots of Lisch nodules and corticonuclear senile cataract of both eyes.
Cognitive dysfunctions, including signifi cant learning diffi culties, behavioral problems, and attention defi cits, are the most common neurological problems associated with NF1. Th e prevalence of Th e presence of two or more Lisch nodules is another cardinal NF1 diagnostic criterion that was also present in our patient. Th ese nodules are small, dome-shaped hyperpigmented macules of the iris that usually do not cause vision impairment. Th ey are commonly seen: in about 15 -20% of patients by the age of six years and in 95% of adults (2, 5) . Th e optic nerve glioma, usually present in 15 -20% of patients with NF1, but not in our case, is another diagnostic NF1 criterion. It is a slow-growing tumor and can present clinically as: proptosis, decreased visual acuity, or precocious puberty (the latter most commonly Malignant peripheral nerve sheath tumor these cognitive defi cits, also present in our patient, approaches 70% (8, 20) . Macrocephaly is another common feature of children with NF1. Macrocephalic subjects show signifi cant increase in volume of the white matter, while increase of the grey matter of the brain has not achieved statistical signifi cance (21) . In contrast, our 78-year-old patient presented with fl attening of the paraventricular gyri and reduction of brain parenchyma with hypodensity of the white matter in terms of cortical atrophy; periventricular bilateral small post-ischemic microvascular lesions of varying chronicity. Other, uncommon but wellknown neurological complications include headaches, sleep disorders, epilepsy, cerebral edema, mental retardation and tumors of the spinal cord and brain (22, 23) .
As our patient had learning diffi culties in early childhood, due to which she did not fi nish elementary school similarly to her brothers and sisters, it can be concluded that she had cognitive disabilities as a neurological manifestation of NF1. In addition, the patient declared frequent headaches in the past two to three decades, the reason why she has been taking analgesics all the time.
Gastrointestinal manifestations of NF-1 are generally unrecognized by both clinicians and pathologists. Th e frequency of intra-abdominal (gastrointestinal or retroperitoneal) manifestations of NF-1 varies greatly in studies, ranging from 5 -25%. Gastrointestinal manifestations usually arise during midlife or later; generally later than cutaneous manifestations. Compared to the cutaneous manifestations, neurogenic tumors are relatively uncommon in the gastrointestinal tract. Th ey may occur at any site from the esophagus to anorectum and in the associated peritoneal and mesenteric soft tissues (24, 25) . Our patient complained of occasional abdominal pain, whereas CT of the abdomen showed distended stomach and a small inner wall herniation.
Th e American Academy of Pediatrics has published diagnostic and health supervision guidelines for children with NF1, which include measurement of blood pressure, as well as assessing children for precocious puberty by annual evaluation of growth and sexual development (26) . NF1 patients have a lifetime risk of 1 -5% for the development of a pheochromocytoma with sustained hypertension in approximately 60% of all cases. Th ese tumors are almost exclusively localized on a single or both adrenal glands. Rarely they are malignant and in most patients can be treated by surgery (27) . Inherited pancreatic endocrine tumors, especially duodenal carcinoids (somatostatinomas) can occur as a part of NF-1, with a penetrance of approximately 1% (28) . In a recent case-control study, hyposalivation was estimated in 59% of 49 individuals with neurofi bromatosis 1. Authors suggested that hyposalivation may be a consequence of NF1, but more studies are needed to prove this hypothesis (29) . No such abnormalities have been detected in our patient.
Patients with NF1 are at increased risk for a variety of cardiovascular disorders (30) . Cardiovascular complications include hypertension, vasculopathy, cardiomyopathy, heart defects and superior vena cava obstruction. Mediastinal neurofi bromas have been well documented as causes of superior vena cava compression. Congenital lesions have potential long-term hemodynamic consequences that justify an early diagnosis (9, 31) . During hospitalization the patient´s blood pressure and electrocardiogram were normal. CT scans revealed a hypotrophic right kidney; atherosclerotic lesions of the abdominal aorta; low grade infrarenal kiking of the abdominal aorta.
A study on NF1 associated mortality included 1895 patients in France; the mortality rate was signifi cantly increased, and malignant nerve sheath tumors were the main cause of death in about 60% of all cases (32) . Cutaneous neurofi bromas are invariably benign but subcutaneous and plexiform neurofi bromas may undergo malignant transformation in about 8 -13% of patients with NF1 (33) . High grade lesions herald a poor prognosis. Th e clinical symptoms include pain, rapid growth, changes in texture and neurological defi cit (34, 35) . Long-term follow-up has shown reduced life expectancy related to the development of malignancy and other tumors that may occur such as gastrointestinal stromal tumors, gastric carcinoid, juvenile myelomonocytic leukemia, glomus tumors, astrocytomas and pheochromocytomas (1, 7) .
Currently, there are no eff ective treatment modalities specifi c for NF1. Th e treatment is symptomatic. Some disfi guring lesions can be excised if not too diff use. Painful and bleeding tumors and cosmetic enhancement warrant surgical intervention, including various surgical techniques and lasers. Th e advent of new treatment options for NF1 such as topical vitamin D3 analogues, lovastatin, rapamycin (or sirolimus), and imatinib mesylate have added new dimensions that require further investigations to prove their therapeutic effi cacy.
We used antibiotic therapy for pneumonia and secondary skin infection in our patient. Considering the age and medical presentation, we did not consider any other treatment.
Genetic counselling is important. It should be made clear to patients that 50% of their children are likely to be aff ected and that the disease may be severe. First-degree relatives (e.g. siblings and off springs) who have no stigmata of the disease are unlikely to carry the gene and the risk for their off springs is small but not absent, as gonadal mosaicism has been observed. Prenatal diagnosis is also not an option for approximately 50% of cases who will present with new mutations (1).
Conclusion
Th is is a sporadic case of cutaneous neurofi bromatosis 1 in a 78-year-old female patient who exhibited extremely severe clinical aspects of cutaneous neurofi bromas, making this case at least rather peculiar.
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